Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Midland Tar Distillers was a prominent British chemical company specializing in the distillation of coal tar to produce a variety of chemical intermediates. The company played a significant role in the supply chain for the pharmaceutical and agrochemical industries, notably producing pyridine and its derivatives used in the synthesis of vitamins and other drugs. Following a merger to become Midland-Yorkshire Tar Distillers, the business was eventually acquired by Croda International in 1975. This acquisition served as a foundational step for Croda's expansion into the life sciences and healthcare sectors. Today, the legacy of the company's chemical expertise persists within Croda's high-performance life science ingredient portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Midland Tar Distillers.